Patent | Date |
---|
Icotinib-containing Topical Skin Pharmaceutical Compositions And Use Thereof App 20190321369 - Wang; Yinxiang ;   et al. | 2019-10-24 |
Polymorphic forms of icotinib phosphate and uses thereof Grant 9,688,687 - Hu , et al. June 27, 2 | 2017-06-27 |
Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors Grant 9,617,257 - Hu , et al. April 11, 2 | 2017-04-11 |
Polymorphic forms of icotinib and uses thereof Grant 9,611,272 - Hu , et al. April 4, 2 | 2017-04-04 |
Polymorphic forms of icotinib maleate and uses thereof Grant 9,505,774 - Hu , et al. November 29, 2 | 2016-11-29 |
Glucagon like peptide analogs, composition, and method of use Grant 9,487,570 - Hu , et al. November 8, 2 | 2016-11-08 |
Icotinib-containing Topical Skin Pharmaceutical Compositions And Uses Thereof App 20160235757 - WANG; Yinxiang ;   et al. | 2016-08-18 |
Compound for increasing kinase active and application thereof Grant 9,409,900 - Kang , et al. August 9, 2 | 2016-08-09 |
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Grant 9,359,370 - Wang , et al. June 7, 2 | 2016-06-07 |
New Polymorphic Forms Of Icotinib Phosphate And Uses Thereof App 20160145262 - HU; Shaojing ;   et al. | 2016-05-26 |
Polymorphic Forms Of Icotinib Maleate And Uses Thereof App 20160137658 - Hu; Shaojing ;   et al. | 2016-05-19 |
Polymorphic Forms Of Icotinib And Uses Thereof App 20160108055 - Hu; Shaojing ;   et al. | 2016-04-21 |
Substituted fused heterocycles as c-Met tyrosine kinase inhibitors Grant 9,242,991 - Hu , et al. January 26, 2 | 2016-01-26 |
Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof Grant 9,238,637 - Kang , et al. January 19, 2 | 2016-01-19 |
Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof Grant 9,206,134 - Kang , et al. December 8, 2 | 2015-12-08 |
NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS App 20150315210 - HU; Shaojing ;   et al. | 2015-11-05 |
Glucagon-like peptide-1 analogues and uses thereof Grant 8,951,959 - Wang , et al. February 10, 2 | 2015-02-10 |
Polymorphic Forms Of Compounds As Prolyl Hydroxylase Inhibitor, And Uses Thereof App 20150031721 - Kang; Xinshan ;   et al. | 2015-01-29 |
Stable Polymorphic Forms of Compound as Hypoxia Mimetics, and Uses Thereof App 20140343137 - Kang; Xinshan ;   et al. | 2014-11-20 |
Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, And Uses Thereof App 20140343082 - Wang; Yinxiang ;   et al. | 2014-11-20 |
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof Grant 8,822,482 - Wang , et al. September 2, 2 | 2014-09-02 |
Compounds as hypoxia mimetics, and compositions and uses thereof Grant 8,742,138 - Kang , et al. June 3, 2 | 2014-06-03 |
Compound For Increasing Kinase Active And Application Thereof App 20130225587 - Kang; Xinshan ;   et al. | 2013-08-29 |
Novel Glucagon Like Peptide Analogs, Composition, and Method of Use App 20130203672 - Hu; Shaojing ;   et al. | 2013-08-08 |
Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors App 20130123286 - Hu; Shaojing ;   et al. | 2013-05-16 |
Glucagon-like Peptide-1 Analogues And Uses Thereof App 20130053304 - Wang; Yinxiang ;   et al. | 2013-02-28 |
Compounds As Hypoxia Mimetics, And Composiitons And Uses Thereof App 20120172399 - Kang; Xinshan ;   et al. | 2012-07-05 |
Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, and Uses Thereof App 20110182882 - Wang; Yinxiang ;   et al. | 2011-07-28 |
Fused quinazoline derivatives useful as tyrosine kinase inhibitors Grant 7,078,409 - Zhang , et al. July 18, 2 | 2006-07-18 |
High-temperature shutdown protecting relay Grant 7,030,722 - Yu , et al. April 18, 2 | 2006-04-18 |
High-temperature Shutdown Protecting Relay App 20060055492 - Yu; Fang ;   et al. | 2006-03-16 |
Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors App 20040048883 - Zhang, Don ;   et al. | 2004-03-11 |